Endovascular treatment of complex diseases of the thoracic aorta—10 years single centre experience

Pathological changes of the thoracic aorta occur in 5–6 cases per million people per year, with aortic aneurysm dissection and rupture being the most common (1). The prognosis of aortic dissection and rupture is poor, and mostly depends on the aortic level. Thus, dissections of the descending part of the aorta are associated with a 65–70% mortality within 4 years, uncomplicated type B dissections with a 30-day mortality of 3%, and a complicated dissection with a 25–50% mortality within 48 hours (1,2). Moreover, the type B complicated dissection, especially with an acute etiology has a very high likelihood of dying and requires emergent open surgical or stent graft treatment (1)